Epitranscriptomic Tuning Broadens In-Vivo CAR Design

Company Osaka University Event Type Publication / Peer-Reviewed Study Modality mRNA-LNP In-Vivo CAR Platform (m6A-Modified) Asset Modular In-Vivo CAR mRNA System (Preclinical) Target FAP / EpCAM / LGR5 / CD133 (Interchangeable) Disease Area Solid Tumors (Preclinical Models) Summary Osaka University researchers report a modular mRNA–lipid-nanoparticle…